1. Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
   Yasuo Tanaka et al, 2018, International Journal of Molecular Sciences CrossRef
2. Progress in basic and clinical research on molecular targeted therapy for primary hepatic carcinoma
   Jian-Ji Li et al, 2019, World Chinese Journal of Digestology CrossRef
3. Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways
   Piao Zheng et al, 2022, World Journal of Gastrointestinal Oncology CrossRef
4. Current status of and progress in the treatment of malignant pleural effusion of lung cancer
   Yuhua Zhao et al, 2023, Frontiers in Oncology CrossRef
5. Synergy of Polydopamine Nanovaccine and Endostar Alginate Hydrogel for Improving Antitumor Immune Responses Against Colon Tumor
   Ying Yang et al, 2022, International Journal of Nanomedicine CrossRef
6. Proteoglycans and Glycosaminoglycans in Cancer
   Giovani Bravin Peres et al, 2023, Handbook of Cancer and Immunology CrossRef
7. Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies
   Raefa Abou Khouzam et al, 2021, Frontiers in Immunology CrossRef
8. Engineering tumor-oxygenated nanomaterials: advancing photodynamic therapy for cancer treatment
   Tingting Zuo et al, 2024, Frontiers in Bioengineering and Biotechnology CrossRef